United States v. Yelaun , 541 F.3d 415 ( 2008 )


Menu:
  •              United States Court of Appeals
    For the First Circuit
    No. 07-1651
    UNITED STATES OF AMERICA,
    Appellee,
    v.
    SEVERIN YELAUN,
    Defendant, Appellant.
    APPEAL FROM THE UNITED STATES DISTRICT COURT
    FOR THE DISTRICT OF MASSACHUSETTS
    [Hon. Nathaniel M Gorton, U.S. District Judge]
    Before
    Torruella and Boudin, and Dyk,*
    Circuit Judges.
    Dana A. Curhan for appellant.
    Mark T. Quinlivan, Assistant United States Attorney, with
    whom Michael J. Sullivan, United States Attorney, was on brief
    for appellee.
    August 27, 2008
    *
    Of the Federal Circuit, sitting by designation.
    BOUDIN, Circuit Judge.    Severin Yelaun appeals from his
    conviction in the federal district court for various federal fraud
    related offenses committed during a scheme to collect insurance
    payments for medical tests.       He also contests his sentence.       The
    events that gave rise to the charges, drawing the facts primarily
    from the government's evidence at Yelaun's trial, are as follows.
    In 1998 Yelaun and Igor Moyseyev started a clinic in
    Massachusetts -- Broadway Physical Therapy and Rehabilitation, Inc.
    ("Broadway") -- to provide physical therapy and diagnostic services
    primarily to auto accident victims. Moyseyev provided the funding,
    while Yelaun recruited physicians and supervised most of the day-
    to-day operations including billing matters; an affiliate,           Global
    Tech    Diagnostics   ("Global   Tech"),   was   incorporated   to   handle
    administrative matters including billing insurers for Broadway's
    services.
    Two of the tests used by Broadway are important to this
    case.    One, the electromyogram ("EMG"), measures nerve and muscle
    function and, as it involves insertion of needles into the patient
    and real time interpretation, requires that a physician be present.
    The second, called a nerve conduction velocity test ("NCV"), also
    measures nerve and muscle function but employs electrodes rather
    than needles. For insurance purposes it requires a prescription or
    request from a doctor, as does an EMG, but unlike the EMG does not
    require the doctor's presence at the test.
    -2-
    Although Broadway did some legitimate testing, it also
    billed auto insurers for numerous EMG and NCV tests that were not
    in fact performed.     The EMG tests were commonly painful; the NCV
    tests involved shocks that could be painful.     At Yelaun's trial a
    number of the patients for whom insurance reimbursement had been
    sought by Global Tech for such tests testified that they had gone
    to Broadway for therapy but had no recollection of the needle
    insertion or electric shocks that were the respective hallmarks of
    the two tests.
    A   doctor    affiliated   with   Broadway,   Dr.   Ranendra
    Chatterjee, testified that his signature stamp had been used
    without authorization to stamp prescriptions for the tests and test
    reports; he said that he had never used the stamp for tests he had
    conducted or reviewed.    Dr. David Tamaren, who worked part-time at
    Broadway, did not testify but prescriptions he wrote for EMG and
    NCV tests were introduced.     The government argued from internal
    evidence that the prescriptions were written after the fact or were
    otherwise fraudulent.
    In mid-1999, Dr. Chatterjee discovered the misuse of his
    stamp and confronted Yelaun, who (Dr. Chatterjee said) admitted
    that the stamp had been used "quite a few times" without the
    doctor's authorization.    Dr. Chatterjee complained to Moyseyev and
    soon thereafter Moyseyev severed his ties with Yelaun. In November
    1999, Yelaun with a new partner formed a new pair of companies --
    -3-
    Orthopedic Physical Therapy & Rehabilitation Center as the provider
    and Lynn Diagnostics Management for billing -- at a new location.
    Dr. John Montoni, a chiropractor who had worked at Broadway and
    followed Yelaun to the Lynn clinic, testified at trial that he had
    written prescriptions for EMG and NCV tests that had never been
    performed.    The same pattern of billing insurers for tests never
    performed was thus repeated at least until some time in 2001 or
    2002.
    In January 2005,   Yelaun, Moyseyev, Dr. Montoni, and Dr.
    Tamaren were indicted on numerous counts including mail fraud, 
    18 U.S.C. § 1341
     (2000), wire fraud, 
    id.
     § 1343, health care fraud,
    id. § 1347,   conspiracy to commit an offense against or defraud the
    United States, id. § 371, money laundering, id. § 1956(a)(1)(A)(i)
    and money laundering conspiracy, id.      § 1956(h).   Yelaun's co-
    defendants accepted plea bargains but Yelaun went to trial and was
    convicted on twenty-six counts of mail fraud and one count each of
    health care fraud, conspiracy to commit an offense against the
    United States, and money laundering conspiracy.
    Following his sentencing -- which yielded a sentence of
    fifty-one months in prison, a term of supervised release, and
    restitution of $88,800.84 -- Yelaun filed the present appeal.    He
    does not contest the sufficiency of the evidence but challenges the
    admission of evidence against him, asserts a fatal variance as to
    -4-
    one count of the indictment and contests his sentence.            The
    standard of review for his claims varies with the issue.
    Yelaun first says that certain trial testimony by Dr.
    Montoni was admitted in error.    Dr. Montoni testified that on a
    specific occasion Yelaun approached him with a box of patient
    charts and asked him to sign prescriptions for EMG and NCV tests
    for those patients.   The tests had already been performed, and   Dr.
    Montoni therefore signed the forms without assessing whether the
    patients needed the tests or not.        Yelaun objects only to the
    doctor's further testimony that he signed the prescriptions as
    Yelaun requested because he felt intimidated by Yelaun.
    Specifically, over objection Dr. Montoni was allowed to
    explain that his reason for signing the prescriptions for tests
    that he had not authorized was that Yelaun frightened him because,
    on a prior occasion, Yelaun had showed anger when Dr. Montoni had
    resisted doing what Yelaun wanted.     Yelaun says that the testimony
    was irrelevant except for the forbidden inference of bad character,
    see Fed. R. Evid. 404(a), and was in any case highly prejudicial
    and therefore inadmissible, Fed. R. Evid. 403.        We will assume
    arguendo that the objections were all properly preserved.
    With limited exceptions, evidence to show the defendant's
    bad character is normally inadmissible in a criminal trial; but the
    very same facts illustrating bad character can be admitted, with a
    limiting instruction if sought, to show something else that is
    -5-
    relevant to the case.     Fed. R. Evid. 404(b).        In this instance, the
    government had ample legitimate reason to explain why at Yelaun's
    behest Dr. Montoni signed prescriptions for tests that he had not
    determined to be medically necessary.
    Absent some explanation as to why Dr. Montoni willingly
    participated in a fraud at Yelaun's request, a jury might well
    infer that Dr. Montoni was not credible but had made up the story
    to secure his plea bargain.        Inevitably, defense counsel was going
    to seek to impeach the doctor based on his own plea bargain with
    the government -- and also with Dr. Montoni's initial statements to
    police   that   he   could   not   remember    signing    the    EMG    and   NCV
    prescriptions.       Both the admitted fraud and the initial denials
    underscored doubts about his credibility.
    The explanation given by Dr. Montoni -- that he was
    afraid of Yelaun based on Yelaun's prior exhibitions of temper --
    tended to make Dr. Montoni's main testimony about Yelaun's demand
    more   plausible,     countering    any    inference   that     Dr.    Montoni's
    signatures had been supplied on his own and without Yelaun's
    involvement.     The context       also tended to counter any potential
    inference that Dr. Montoni -- who had in some instances properly
    prescribed such tests for patients -- was simply confused or
    mistaken about the episode in question.
    Case law supports the relevance and admissibility of such
    contextual testimony. United States v. Bartelho, 
    129 F.3d 663
    , 676
    -6-
    (1st Cir. 1997), cert. denied, 
    525 U.S. 905
     (1998) (allowing
    defendant's girlfriend to testify that she was intimidated by him
    to explain why she initially lied to the police and committed
    perjury); cf. United States v. Balsam, 
    203 F.3d 72
    , 85 (1st Cir.),
    cert. denied, 
    531 U.S. 852
     (2000) (defendant's former girlfriend
    allowed to testify that she feared him to explain her reluctance to
    testify).   In any event, the evidence was logically relevant for a
    reason other than bad character, which is Rule 404(b)'s ultimate
    test.
    Of course, relevant evidence can be excluded under Rule
    403 if it is substantially more prejudicial than "probative" (i.e.,
    tending to prove a fact in issue), but this is a fact-specific
    balancing judgment by the trial judge reviewed only for abuse of
    discretion. United States v. Rodriguez-Estrada, 
    877 F.2d 153
    , 155-
    56 (1st Cir. 1989).   In this case, the fact that Yelaun had a bad
    temper and that Dr. Montoni feared him was relevant and at best
    minimally prejudicial: the crime charged, after all, was fraud, not
    assault, and bad temper does not normally suggest a propensity to
    commit fraud.
    Yelaun's more interesting claim of error is that there
    was a variance between the indictment's count 43, which charged him
    with conspiracy to commit money laundering, and the proof at trial.
    Count 43, on which Yelaun was convicted, charged that from in or
    about January 1999 through in or after 2002, Yelaun and Moyseyev:
    -7-
    did knowingly and unlawfully conspire with
    each other and with others known and unknown
    to the Grand Jury, knowingly to conduct and
    attempt to conduct financial transactions
    affecting interstate and foreign commerce,
    that is, to engage in financial transactions
    involving United States currency and bank
    checks, which in fact involved the proceeds of
    specified unlawful activity, that is, Mail
    Fraud in violation of Title 18, United States
    Code, Section[] 1341, Wire Fraud in violation
    of Title 18, United States Code, Section 1343,
    and Health Care Fraud in violation of Title
    18, United States Code, Section 1347, with
    intent to promote the carrying on of said
    specified unlawful activity, and knowing that
    the transactions were designed in whole and in
    part to conceal and disguise the nature,
    location, source, ownership, and control of
    the proceeds of that specified unlawful
    activity, and knowing, while conducting and
    attempting    to   conduct   such    financial
    transactions, that the property involved in
    the financial transactions represented the
    proceeds of some form of unlawful activity, in
    violation of 
    18 U.S.C. §1956
    (a)(1)(A)(i) and
    (B)(i).
    The substantive money laundering counts (counts 44 to 58)
    identified checks that Global Tech gave Symco Medical Billing, an
    outside collection agency hired by Global Tech and Lynn to handle
    some billing and collections, and two checks to Global Tech's
    accountant.   At trial, the government dismissed the substantive
    money   laundering   counts.   To    prove   count   43,   the   government
    introduced Global Tech checks given to Broadway employees and to
    Yelaun for legitimate purposes (e.g., as salary checks).
    Yelaun's objection, at trial and on appeal, is that the
    use of the employee checks was a "variance" from the indictment
    -8-
    because count 43 had (although not expressly so) relied only upon
    the checks paid to Symco and the Global Tech accountant identified
    in withdrawn counts 43-58, which charged specific acts of money
    laundering.     Yelaun does not dispute that the employee checks were
    a rational means of showing both the laundering of the funds and
    their use to promote the enterprise, just as charged in the
    indictment.     The objection is to the alleged variance.
    A    variance       occurs    when    the     crime   charged    remains
    unaltered, but the evidence adduced at trial proves different facts
    than those alleged in the indictment. United States v. Mueffelman,
    
    470 F.3d 33
    , 38 (1st Cir. 2006).                A variance does not warrant
    reversal   unless    it    is    prejudicial,     e.g.,     by   undermining      the
    defendant's right "to 'have sufficient knowledge of the charge
    against him . . . to prepare an effective defense and avoid
    surprise at trial, and to prevent a second prosecution for the same
    offense.'"     United States v. DeCicco, 
    439 F.3d 36
    , 47 n.4 (1st Cir.
    2006) (quoting United States v. Tormos-Vega, 
    959 F.2d 1103
    , 1115
    (1st Cir.), cert. denied, 
    506 U.S. 866
     (1992)).
    Here, there was no variance at all, prejudicial or
    otherwise.      Count     43    did     not   identify    any    checks    or   other
    transactions as the basis for that count.                The defense could have
    sought a bill of particulars to identify specific transactions,
    United States v. Barbato, 
    471 F.2d 918
    , 921 (1st Cir. 1973), but it
    did not.   At best, the defense could merely have assumed -- wrongly
    -9-
    as it turned out -- that the government would rely on transactions
    mentioned in the substantive money laundering counts to prove the
    conspiracy. Using different transactions did not "vary" any proof
    promised by count 43 because the count identified no specific
    transactions.
    Relatedly, Yelaun says that he was unfairly surprised by
    the use of the employee checks because the government misled him by
    telling him it was going to rely on the checks listed in the
    substantive money laundering counts to prove count 43.                  No support
    for this claim is supplied; in fact, the government produced the
    checks to employees in pretrial discovery, listed them as exhibits
    to be introduced, and argued in its opening that it would be
    relying on the checks to employees to prove count 43.
    Further,    when   Yelaun   objected      to   the    offer   of    the
    employee checks, government counsel at sidebar said that the
    prosecution     had     explicitly    told   Yelaun's       counsel     that     the
    government intended to rely on the employee checks to prove count
    43; nothing indicates that defense counsel disputed this assertion.
    If   the   defense    wanted    a   formal   inquiry    into      the   matter   of
    representations, or a delay in the trial to counter the supposed
    surprise evidence, the time to ask was at the trial.               United States
    v. Wright, 
    573 F.2d 681
    , 685 (1st Cir.), cert. denied, 
    436 U.S. 949
    (1978); United States v. Antonelli, 
    439 F.2d 1068
    , 1070 (1st Cir.
    1971).     No such request was made.
    -10-
    Finally, Yelaun challenges two sentencing enhancements
    adopted by the trial judge in calculating the guideline range for
    Yelaun's sentence.    Using the 2002 version of the guidelines, the
    judge adopted an adjusted offense level of twenty-four which, with
    Yelaun's criminal history level I, yielded a guideline range of
    fifty-one to sixty-three months. Yelaun's fifty-one month sentence
    was at the bottom of the range.        A mistake in calculating the range
    could conceivably have affected the sentence, but there was no
    mistake.
    In finding an offense level of level twenty-four, the
    district judge identified a base offense level of six for fraud,
    U.S.S.G. § 2B1.1(a), and then added a ten level enhancement for
    causing an amount of loss between $120,000 and $200,000, U.S.S.G.
    § 2B1.1(b)(1)(F), a two level enhancement for a scheme involving
    more   than    ten   but   less   than       fifty   victims,     U.S.S.G.   §
    2B1.1(b)(2)(A)(i), a four level enhancement based on Yelaun's role
    as an organizer or leader of a criminal activity that involved five
    or   more   participants   or   was    otherwise     extensive,   U.S.S.G.   §
    3B1.1(a), and a two level enhancement for obstruction of justice,
    see U.S.S.G. § 3C1.1.
    Yelaun first challenges the amount-of-loss calculation on
    two different grounds -- one legal and one factual.                 His legal
    objection, which we review de novo, is that the judge rather than
    a jury found the facts establishing the amount of loss under the
    -11-
    guidelines and that this violates the Sixth Amendment.    But United
    States v. Booker, 
    543 U.S. 220
     (2005), resolved this concern by
    making the guidelines advisory.    See United States v. Ziskind, 
    491 F.3d 10
    , 17 (1st Cir. 2007), cert. denied, 
    128 S. Ct. 1305
     (2008).
    It is only where the findings at issue (here, the loss findings)
    raise the statutory maximum sentence or constitute an element of
    the crime that a jury finding is necessary.      Booker, 543 U.S. at
    230-37, 244; United States v. Bermudez, 
    407 F.3d 536
    , 545 (1st
    Cir.), cert. denied, 
    546 U.S. 921
     (2005).    Neither is true in this
    instance.
    Yelaun's factual challenge to the computation is that the
    evidence failed to show a loss of at least $120,000.    The district
    judge calculated the loss as $179,534.74, which reflected all EMG
    and NCV tests billed by Global Tech or Lynn Diagnostics with test
    reports were signed by Dr. Montoni or stamped with Dr. Chatterjee's
    signature stamp. Conceding that the EMG losses were proven, Yelaun
    says that there was insufficient evidence that the NCV tests were
    not performed.     Review is for clear error.      United States v.
    Phaneuf, 
    91 F.3d 255
    , 261 (1st Cir. 1996).
    Dr. Chatterjee testified that he never authorized the use
    of, nor in fact used, his signature stamp to sign any NCV reports,
    so any NCV reports bearing his signature stamp were based on
    fraudulent documents.    Dr. Montoni was not authorized to perform
    NCV tests and testified that he had never performed any such tests,
    -12-
    and that he did not know whether the tests in the reports he signed
    had been performed.       Thus, insurance claims based on test reports
    bearing his signature were supported by fraudulent documents. This
    would be enough standing alone to support the loss finding, but
    there is more.
    Dr. Montoni testified that several of the tests bearing
    his signature were identical for different patients, a virtual
    impossibility     if    the    tests       were   legitimate.       Dr.     Chatterjee
    similarly    testified        that    some    patients'    reports     bearing     his
    signature stamps were identical and that Global Tech had billed for
    up to fifteen tests signed by him in a day, which he testified he
    had not performed.       All this, with the patient testimony as well,
    provided more than enough evidence to support the loss calculation
    adopted by the district judge.
    Yelaun also disputes the four level enhancement for being
    a leader or organizer of a conspiracy that involved five or more
    participants or was otherwise extensive.                  U.S.S.G. § 3B1.1.        He
    contests both prongs of the enhancement, arguing that he was not an
    organizer or leader of the conspiracy and that the conspiracy did
    not   involve    five   or    more     participants     and   was     not   otherwise
    extensive.      As to the second prong, a finding that the conspiracy
    was   otherwise    extensive         was   sufficient     with   or   without    five
    participants.
    -13-
    Yelaun's argument as to his role as an organizer or
    leader is, in essence, that he was a subordinate of Moyseyev, who
    controlled Broadway and who ultimately fired Yelaun.            In fact, the
    testimony at trial showed that Yelaun played a major role at
    Broadway in its day-to-day operations. He had greater knowledge of
    the business than Moyseyev and was in charge of finding doctors,
    scheduling, running the billing and training the administrative
    staff.     See U.S.S.G. § 3B1.1, cmt. 4 (setting forth criteria for
    leader or organizer; more than one individual can so qualify).
    As to Lynn Diagnostics, it appears that Yelaun's control
    was at least as great as at Broadway.           He recruited Drs. Tamaren
    and Montoni for the new enterprise, ran the billing and seems to
    have generally been running the day-to-day operations. The outside
    billing company he worked with believed he owned Lynn.             Even with
    fewer specifics, it would be a fair inference that his importance
    and role were at least as significant in the new and smaller
    company as in its predecessor.
    Yelaun says that in determining that the conspiracy was
    extensive,    the   judge   conflated   the   two   different     enterprises
    successively operated by Yelaun; but each involved the services of
    numerous     employees   and   a   fairly     complex   scheme,    involving
    falsifying medical reports and prescriptions and follow up billings
    based on that false documentation. Cf. United States v. Twitty, 
    72 F.3d 228
    , 234 (1st Cir. 1995).       Either scheme could be considered
    -14-
    "otherwise extensive" in its own right.   So the enhancement was
    proper regardless of the number of employees.
    Affirmed.
    -15-